Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDAlexion Pharmaceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 04/30/2021 | Q1 2021 | $3.16 | $2.89 | -0.27 | N/A | $1.64 B |
| 02/08/2021 | Q4 2020 | N/A | $2.45 | N/A | N/A | $1.59 B |
| 10/29/2020 | Q3 2020 | $2.60 | $2.64 | 0.04 | N/A | $1.59 B |
| 07/30/2020 | Q2 2020 | $2.59 | -$4.84 | -7.43 | N/A | $1.44 B |
| 05/06/2020 | Q1 2020 | $2.71 | $2.52 | -0.19 | N/A | $1.44 B |
| 02/04/2020 | Q4 2019 | N/A | $4.02 | N/A | N/A | $1.38 B |
| 10/23/2019 | Q3 2019 | $2.47 | $2.09 | -0.38 | N/A | $1.26 B |
| 07/24/2019 | Q2 2019 | $2.34 | $2.05 | -0.29 | N/A | $1.20 B |
| 04/25/2019 | Q1 2019 | $2.19 | $2.63 | 0.44 | N/A | $1.14 B |
| 02/06/2019 | Q4 2018 | N/A | -$0.20 | N/A | N/A | $1.13 B |
| 10/24/2018 | Q3 2018 | $1.74 | $1.48 | -0.26 | N/A | $1.03 B |
| 07/26/2018 | Q2 2018 | $1.70 | -$2.05 | -3.75 | N/A | $1.05 B |
| 04/26/2018 | Q1 2018 | $1.50 | $1.12 | -0.38 | N/A | $930.90 M |
| 02/08/2018 | Q4 2017 | $1.27 | $0.14 | -1.13 | N/A | $910.10 M |
| 10/26/2017 | Q3 2017 | $1.32 | $0.35 | -0.97 | N/A | $859.00 M |
| 07/27/2017 | Q2 2017 | $1.26 | $0.74 | -0.52 | N/A | $912.00 M |
| 04/27/2017 | Q1 2017 | $1.23 | $0.76 | -0.47 | N/A | $870.00 M |
| 01/04/2017 | Q4 2016 | N/A | $0.41 | N/A | N/A | $830.74 M |
| 01/04/2017 | Q3 2016 | N/A | $0.42 | N/A | N/A | $799.11 M |
| 07/29/2016 | Q2 2016 | N/A | $0.51 | N/A | N/A | $753.12 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Alexion Pharmaceuticals, Inc. Earnings: FAQ's
Alexion Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, July 29th, 2021 based offlast year's report dates.
In the previous quarter, Alexion Pharmaceuticals, Inc. (:ALXN) reported $3.52 earnings per share (EPS) to beat the analysts' consensus estimate of $3.16 by $0.36.
The conference call for Alexion Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Alexion Pharmaceuticals, Inc.'s latest earnings report can be read online.
Alexion Pharmaceuticals, Inc. (:ALXN) has a recorded annual revenue of $6.07 B.
Alexion Pharmaceuticals, Inc. (:ALXN) has a recorded net income of $603.40 M.Alexion Pharmaceuticals, Inc. has generated $2.75 earnings per share over the last four quarters.
Alexion Pharmaceuticals, Inc. (:ALXN) has a price-to-earnings ratio of 66.27 and price/earnings-to-growth ratio is 0.66.